Atlas Trials

Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control

Clinical trial NCT01066039 · COMPLETED

Trial details

NCT number
NCT01066039
Sponsor
Merck KGaA, Darmstadt, Germany
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HypertensionDiabetes Mellitus, Type II
Start date
2010-04-01
Primary completion
2013-04-01
Enrollment
202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.